glp 1 drugs and addiction Not just obesity: GLP-1 receptor agonists advance on GLP-1s may have potential to
Description
Heart Health: GLP-1 agonists have significant cardiovascular benefits
[DOI] [PubMed] [Google Scholar] 624.Green B.D., Hand K.V., Dougan J.E., McDonnell B.M., Cassidy R.S., Grieve D.J
When GLP-1s became popular for weight loss, the market saw a shortage of them, which is why the FDA allowed compounding pharmacies to begin formulating non-branded, compounded versions of them
In preclinical studies, GLP-1RAs are typically administered before or immediately after the onset of pathology, whereas clinical trials have enrolled mild-to-moderate symptomatic cohorts
The funders of this study had no role in design and conduct of the study
